Biocon, Biocon Biologics India (BBIL) and Activ Pine LLP (an affiliate of True North Fund VI LLP) have executed a share subscription agreement and a shareholder agreement. The Company currently holds 93.27% of the share capital of BBIL, on a fully diluted basis. Pursuant to the agreement, True North Fund VI LLP shall subscribe to 50.25 lakh equity shares of BBIL, at a price of Rs 1,067.07 per equity share.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.
